Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04445584 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

7 Tesla MRI Evaluation of the Spine (Asymptomatic)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv5
  2. Notable Enrollment target: 80 to 600v4 Show 5 more changesShow less
    • Trial status: Completed to Recruiting
    • Study completion date: Feb 1, 2022 to Sep 30, 2027
    • Eligibility criteria expanded, about 25 words
    • Site details revised
    • Study title shortened, about 3 words
  3. Notable Primary completion date changed from estimate of Jun 1, 2021 to Feb 1, 2022v3 Show 4 more changesShow less
    • Trial status: Recruiting to Completed
    • Enrollment target: estimated 200 to confirmed 80
    • Study completion date changed from estimate of Dec 1, 2021 to Feb 1, 2022
    • Site details revised
  4. Notable Primary endpoint revised
    • Secondary endpoint revised
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
High-resolution MRI (7 Tesla) of the cervical spine is capable to provide good differentiation between nerve and surrounding tissues within foramen und allows to reliably quantify the diameter of nerve roots/ganglia. Secondly, detailed anatomy of vertebral artery and its relation to neural structures / foramina can be assessed.
Trial Details
NCT Number NCT04445584
Lead Sponsor Balgrist University Hospital
Conditions
(from sponsor)
Magnetic Resonance Imaging, Cervical Spine Anatomy, Reference Standard
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov